TY - JOUR
T1 - Incidence and impact of parvovirus B19 infection in seronegative solid organ transplant recipients
AU - Rezahosseini, Omid
AU - Ekenberg, Christina
AU - Møller, Dina Leth
AU - Sørensen, Søren Schwartz
AU - Wareham, Neval Ete
AU - Perch, Michael
AU - Gustafsson, Finn
AU - Rasmussen, Allan
AU - Kirkby, Nikolai
AU - Reekie, Joanne
AU - Lundgren, Jens
AU - Nielsen, Susanne Dam
N1 - © The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: [email protected].
PY - 2021/9/1
Y1 - 2021/9/1
N2 - Routine monitoring of parvovirus B19 (B19V) the first 6 months posttransplantation was performed in 241 seronegative solid organ transplant (SOT) recipients. Incidence rates during the first month and the second to sixth months posttransplantation were 1.2 (95% confidence interval [CI], .33-3.2) and 0.21 (95% CI, .06-.57) per 100 recipients per month, respectively. Of the 6 SOT recipients with positive B19V polymerase chain reaction, 3 (50%) were admitted to hospital and 2 (33%) were treated with intravenous immunoglobulin. Thus, routine monitoring of B19V in seronegative SOT recipients may not be necessary. Targeted screening 1 month posttransplantation and screening upon clinical suspicion could be an alternative strategy.
AB - Routine monitoring of parvovirus B19 (B19V) the first 6 months posttransplantation was performed in 241 seronegative solid organ transplant (SOT) recipients. Incidence rates during the first month and the second to sixth months posttransplantation were 1.2 (95% confidence interval [CI], .33-3.2) and 0.21 (95% CI, .06-.57) per 100 recipients per month, respectively. Of the 6 SOT recipients with positive B19V polymerase chain reaction, 3 (50%) were admitted to hospital and 2 (33%) were treated with intravenous immunoglobulin. Thus, routine monitoring of B19V in seronegative SOT recipients may not be necessary. Targeted screening 1 month posttransplantation and screening upon clinical suspicion could be an alternative strategy.
UR - http://www.scopus.com/inward/record.url?scp=85121331545&partnerID=8YFLogxK
U2 - 10.1093/infdis/jiab024
DO - 10.1093/infdis/jiab024
M3 - Journal article
C2 - 33458766
SN - 0022-1899
VL - 224
SP - 865
EP - 869
JO - The Journal of infectious diseases
JF - The Journal of infectious diseases
IS - 5
ER -